| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.4 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |